Evidence map›Paper›PMID 28631214›Full record

ArticleMicrobial ecology2017

Identification of Bufadienolides from the Boreal Toad, Anaxyrus boreas, Active Against a Fungal Pathogen.

Kelly Barnhart, Megan E Forman, Thomas P Umile, Jordan Kueneman, Valerie McKenzie, Irene Salinas, Kevin P C Minbiole, Douglas C Woodhams

Abstract read
PubMed Publisher
In one paragraph

Article in Microbial ecology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Antifungal Effect ofInternational journal of molecular sciences · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Kelly BarnhartDepartment of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA.
Megan E FormanDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA.
Thomas P UmileDivision of Natural and Computational Science, Gwynedd Mercy University, Gwynedd Valley, PA, 19437, USA.
Jordan KuenemanDepartment of Ecology and Evolutionary Biology, University of Colorado, Ramaley N122, UCB 334, Boulder, CO, 80309, USA.
Valerie McKenzieDepartment of Ecology and Evolutionary Biology, University of Colorado, Ramaley N122, UCB 334, Boulder, CO, 80309, USA.
Irene SalinasDepartment of Biology, University of New Mexico, Albuquerque, NM, 87131-0001, USA.
Kevin P C MinbioleDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA. kevin.minbiole@villanova.edu.
Douglas C WoodhamsDepartment of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA. dwoodhams@gmail.com.ORCID 0000-0003-4559-1046
University of Colorado Boulder · USUniversity of Massachusetts Boston · USVillanova University · USGwynedd Mercy University · USUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amphibian granular glands provide a wide range of compounds on the skin that defend against pathogens and predators. We identified three bufadienolides-the steroid-like compounds arenobufagin, gamabufotalin, and telocinobufagin-from the boreal toad, Anaxyrus boreas, through liquid chromatography mass spectrometry (LC/MS). Compounds were detected both after inducing skin gland secretions and in constitutive mucosal rinses from toads. We described the antimicrobial properties of each bufadienolide against Batrachochytrium dendrobatidis (Bd), an amphibian fungal pathogen linked with boreal toad population declines. All three bufadienolides were found to inhibit Bd growth at similar levels. The maximum Bd inhibition produced by arenobufagin, gamabufotalin, and telocinobufagin were approximately 50%, in contrast to the complete Bd inhibition shown by antimicrobial skin peptides produced by some amphibian species. In addition, skin mucus samples significantly reduced Bd viability, and bufadienolides were detected in 15 of 62 samples. Bufadienolides also appeared to enhance growth of the anti-Bd bacterium Janthinobacterium lividum, and thus may be involved in regulation of the skin microbiome. Here, we localized skin bacteria within the mucus layer and granular glands of toads with fluorescent in situ hybridization. Overall, our results suggest that bufadienolides can function in antifungal defense on amphibian skin and their production is a potentially convergent trait similar to antimicrobial peptide defenses found on the skin of other species. Further studies investigating bufadienolide expression across toad populations, their regulation, and interactions with other components of the skin mucosome will contribute to understanding the complexities of amphibian immune defense.

Indexed as

AnimalsAntifungal AgentsBufanolidesBufonidaeChytridiomycotaAntifungal AgentsBufanolidesAmphibianBoreal toadBufadienolidesChytridiomycosisImmune defense

Identifiers

PMID28631214
OpenAlexW2650652429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.